Articles Tagged with product liability lawyer

Facing hundreds of personal injury product liability lawsuits over defective ignition switches, General Motors this year has faced down the first of thousands of these cases. Surprisingly, the company thus far has been fairly successful. The first three cases ended in their favor, with two of them dismissed (one after plaintiff was deemed not credible) and a third following a trial in which jurors decided the vehicle in question was defective and unreasonably dangerous, but it wasn’t the cause of plaintiff’s injuries. driver

Now, the company has chosen for the first time to settle one of these bellwether cases. That’s critical here because it could well determine how the company proceeds with other pending product defect lawsuits – particularly those that ended in fatality.

The auto manufacturer has recalled some 2.6 million of its small cars with the faulty ignition switch issue, which causes power to be suddenly cut from a moving vehicle. Not only is that especially dangerous because it causes a driver to lose control of the vehicle, it also shuts down critical safety systems, like airbags and brakes.  Continue reading

The manufacturer of Eliquis is now claiming there has been a reduction in deaths for Afib patients who take the anticoagulant medication, but a review at the United States Food and Drug Administration is questioning this allegation, according to a recent news article from the Journal Sentinel.

pillsEliquis is one of what are now four new anticoagulants on the market to treat a medical condition known as atrial fibrillation (Afib). Afib is characterized as a disease associated with an irregular heartbeat that leads to the formation of blood clots, and, if these clots end up blocking blood to the brain, they can cause the patient to have a stroke. For this reason, the patient must take either a blood thinner, which was the preferred form of therapy for years, or one of the new oral anticoagulants (NOACs), including Xarelto, Eliquis, Pradaxa and Savaysa.

That last one, Savaysa, just received FDA approval and was brought to market earlier this year. Continue reading